Page last updated: 2024-11-05

5-nitro-2-methoxyaniline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-nitro-2-methoxyaniline: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7447
CHEMBL ID319398
CHEBI ID48977
SCHEMBL ID269845
MeSH IDM0105272

Synonyms (88)

Synonym
nsc-5510
5-nitro-2-methoxyaniline
o-anisidine, 5-nitro-
3-nitro-6-methoxyaniline
2-amino-1-methoxy-4-nitrobenzene
5-nitro-o-anisidine
nci-c01934
wln: wnr cz do1
2-methoxy-5-nitroaniline
99-59-2
nsc5510
2-amino-4-nitroanisole
benzenamine, 2-methoxy-5-nitro-
azoamine scarlet k
einecs 202-770-5
azoic diazo component 13, base
ai3-08934
nsc 5510
azogene ecarlate r
brn 0879620
o-anisidine nitrate
5-nitro-ortho-anisidine
aniline, 2-methoxy-5-nitro-
3-amino-4-methoxynitrobenzene
hsdb 4104
ci azoic diazo component 13
c.i. 37130
azoamine scarlet
ccris 440
c.i. azoic diazo component 13
NCGC00091266-01
inchi=1/c7h8n2o3/c1-12-7-3-2-5(9(10)11)4-6(7)8/h2-4h,8h2,1h
fast scarlet r
2-methoxy-5-nitrobenzenamine
CHEBI:48977 ,
2-methoxy-5-nitroaniline, 98%
NCGC00091266-02
STK399982
AKOS000498225
AN-652/40187552
CHEMBL319398
M0492
NCGC00091266-03
NCGC00091266-04
C19469
NCGC00254158-01
dtxcid60943
cas-99-59-2
NCGC00259185-01
dtxsid0020943 ,
tox21_201636
tox21_300122
2-methoxy-5-nitro-phenylamine
ci 37130
4-nitro-2-aminoanisole
4-nitro-2-anisidine
ec 202-770-5
unii-thy70utm0o
thy70utm0o ,
FT-0612807
2-amino-4-nitro anisidine
1-methoxy-2-amino-4-nitrobenzene
(2-methoxy-5-nitrophenyl)amine
5-nitro-ortho-anisidine [iarc]
1-amino-2-methoxy-5-nitrobenzene
5-nitro-2-methoxyaniline [hsdb]
2-(methyloxy)-5-nitroaniline
2-amino-4-nitro anisole
SCHEMBL269845
2methoxy-5-nitroaniline
2-methoxy 5-nitro aniline
2-amino-4-nitroanisol
2-methoxy-5-nitro phenylamine
2-methoxy-5-nitro aniline
2-methoxyl-5-nitroaniline
2-amino-4-nitro-1-methoxybenzene
W-109372
CS-0015286
mfcd00007261
F0020-2000
AS-58184
Q27121416
YSZC2421
SY002529
AMY40951
D72503
EN300-16794
Z56782014
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
4-nitroanisolesAny member of the class of mononitroanisoles in which the nitro group is situated para to the methoxy group.
substituted aniline
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (12)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency44.66840.004023.8416100.0000AID485290
pregnane X receptorRattus norvegicus (Norway rat)Potency63.09570.025127.9203501.1870AID651751
AR proteinHomo sapiens (human)Potency58.04180.000221.22318,912.5098AID1259243; AID1259381
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency38.67700.001022.650876.6163AID1224838; AID1224893
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency53.26620.003041.611522,387.1992AID1159552; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency69.16910.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency10.98300.000229.305416,493.5996AID743069; AID743075
aryl hydrocarbon receptorHomo sapiens (human)Potency57.29540.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency55.98060.001723.839378.1014AID743083
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency11.22020.010039.53711,122.0200AID588547
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency28.97190.000627.21521,122.0200AID651741; AID720636
Nuclear receptor ROR-gammaHomo sapiens (human)Potency13.33320.026622.448266.8242AID651802
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
negative regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
xenobiotic metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of glucose metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
regulation of steroid metabolic processNuclear receptor ROR-gammaHomo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor ROR-gammaHomo sapiens (human)
circadian regulation of gene expressionNuclear receptor ROR-gammaHomo sapiens (human)
cellular response to sterolNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of circadian rhythmNuclear receptor ROR-gammaHomo sapiens (human)
regulation of fat cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor ROR-gammaHomo sapiens (human)
adipose tissue developmentNuclear receptor ROR-gammaHomo sapiens (human)
T-helper 17 cell differentiationNuclear receptor ROR-gammaHomo sapiens (human)
regulation of transcription by RNA polymerase IINuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (10)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificNuclear receptor ROR-gammaHomo sapiens (human)
DNA-binding transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
protein bindingNuclear receptor ROR-gammaHomo sapiens (human)
oxysterol bindingNuclear receptor ROR-gammaHomo sapiens (human)
zinc ion bindingNuclear receptor ROR-gammaHomo sapiens (human)
ligand-activated transcription factor activityNuclear receptor ROR-gammaHomo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor ROR-gammaHomo sapiens (human)
nuclear receptor activityNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
nucleoplasmNuclear receptor ROR-gammaHomo sapiens (human)
nuclear bodyNuclear receptor ROR-gammaHomo sapiens (human)
chromatinNuclear receptor ROR-gammaHomo sapiens (human)
nucleusNuclear receptor ROR-gammaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID233323Activity expressed by taste potency (taste intensity relative to sucrose on a mole/mole basis)1980Journal of medicinal chemistry, Mar, Volume: 23, Issue:3
Structure--taste relationship of perillartine and nitro- and cyanoaniline derivatives.
AID433903Hepatotoxicity in mouse assessed as carcinogenic potency2009European journal of medicinal chemistry, Sep, Volume: 44, Issue:9
Development of QSAR models for predicting hepatocarcinogenic toxicity of chemicals.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (42.86)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]